Page last updated: 2024-08-23

tridemorph and gefitinib

tridemorph has been researched along with gefitinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Antonaci, S; Azzariti, A; Fransvea, E; Giannelli, G; Paradiso, A; Porcelli, L	1

Other Studies

1 other study(ies) available for tridemorph and gefitinib

Article	Year
Laminin-5 offsets the efficacy of gefitinib ('Iressa') in hepatocellular carcinoma cells. British journal of cancer, 2004, Nov-29, Volume: 91, Issue:11 Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Adhesion Molecules; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Humans; Kalinin; Phosphorylation; Predictive Value of Tests; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Quinazolines	2004

Article

Year

Laminin-5 offsets the efficacy of gefitinib ('Iressa') in hepatocellular carcinoma cells.

British journal of cancer, 2004, Nov-29, Volume: 91, Issue:11

Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Adhesion Molecules; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Humans; Kalinin; Phosphorylation; Predictive Value of Tests; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Quinazolines

2004